Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Inc., 71767 [2016-25133]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 201 / Tuesday, October 18, 2016 / Notices
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
September 5, 2016, Johnson Matthey
Inc., Pharmaceutical Materials, 2003
Nolte Drive, West Deptford, New Jersey
08066–1742, applied to be registered as
an importer of the following basic
classes of controlled substances:
Controlled substance
Coca Leaves ................
Thebaine .......................
Opium, raw ...................
Noroxymorphone ..........
Poppy Straw Concentrate.
Fentanyl ........................
Drug
code
Schedule
9040
9333
9600
9668
9670
II
II
II
II
II
9801
II
The company plans to import
Thebaine derivatives and Fentanyl as
reference standards. The company plans
to import the remaining listed
controlled substances as raw materials,
to be used in the manufacture of bulk
controlled substances, for distribution to
its customers.
Dated: October 11, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–25126 Filed 10–17–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before December 19, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Lhorne on DSK30JT082PROD with NOTICES
DATES:
VerDate Sep<11>2014
13:19 Oct 17, 2016
Jkt 241001
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
September 5, 2016, Johnson Matthey
Inc., Custom Pharmaceuticals
Department, 2003 Nolte Drive, West
Deptford, New Jersey 08066–1742
applied to be registered as a bulk
manufacturer the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled Substance
Gamma Hydroxybutyric
Acid.
Marihuana .....................
Tetrahydrocannabinols
Dihydromorphine ..........
Difenoxin .......................
Propiram .......................
Amphetamine ...............
Methamphetamine ........
Lisdexamfetamine ........
Methylphenidate ...........
Nabilone .......................
Cocaine ........................
Codeine ........................
Dihydrocodeine .............
Oxycodone ...................
Hydromorphone ............
Diphenoxylate ...............
Ecgonine .......................
Hydrocodone ................
Meperidine ....................
Methadone ....................
Methadone intermediate
Morphine .......................
Thebaine .......................
Oxymorphone ...............
Noroxymorphone ..........
Alfentanil .......................
Remifentanil ..................
Sufentanil ......................
Tapentadol ....................
Fentanyl ........................
PO 00000
Frm 00079
Fmt 4703
Drug
code
Schedule
2010
I
7360
7370
9145
9168
9649
1100
1105
1205
1724
7379
9041
9050
9120
9143
9150
9170
9180
9193
9230
9250
9254
9300
9333
9652
9668
9737
9739
9740
9780
9801
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Sfmt 4703
71767
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers.
In reference to drug codes 7360
(marihuana) and 7370 (THC), the
company plans to bulk manufacture
these drugs as synthetics. No other
activities for these drug codes are
authorized for this registration.
Dated: October 11, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–25133 Filed 10–17–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Wage and Hour Division
Agency Information Collection
Activities; Comment Request;
Information Collections: Report of
Construction Contractor’s Wage Rates
Wage and Hour Division,
Department of Labor.
ACTION: Notice.
AGENCY:
The Department of Labor
(DOL) is soliciting comments
concerning a proposed extension of the
information collection request (ICR)
titled, ‘‘Report of Construction
Contractor’s Wage Rates.’’ This
comment request is part of continuing
Departmental efforts to reduce
paperwork and respondent burden in
accordance with the Paperwork
Reduction Act of 1995 (PRA), 44 U.S.C.
3501 et seq.
This program helps to ensure that
requested data can be provided in the
desired format, reporting burden (time
and financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. A copy of the
proposed information request can be
obtained by contacting the office listed
below in the FOR FURTHER INFORMATION
CONTACT section of this Notice.
DATES: Written comments must be
submitted to the office listed in the
ADDRESSES section below on or before
December 19, 2016.
ADDRESSES: You may submit comments
identified by Control Number 1235–
0015, by either one of the following
methods: Email: WHDPRAComments@
dol.gov; Mail, Hand Delivery, Courier:
Division of Regulations, Legislation, and
Interpretation, Wage and Hour, U.S.
Department of Labor, Room S–3502, 200
Constitution Avenue NW., Washington,
DC 20210. Instructions: Please submit
one copy of your comments by only one
SUMMARY:
E:\FR\FM\18OCN1.SGM
18OCN1
]]>Agencies
[Federal Register Volume 81, Number 201 (Tuesday, October 18, 2016)]
[Notices]
[Page 71767]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-25133]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before December 19, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Office of Diversion Control
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
September 5, 2016, Johnson Matthey Inc., Custom Pharmaceuticals
Department, 2003 Nolte Drive, West Deptford, New Jersey 08066-1742
applied to be registered as a bulk manufacturer the following basic
classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled Substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Dihydromorphine........................ 9145 I
Difenoxin.............................. 9168 I
Propiram............................... 9649 I
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Lisdexamfetamine....................... 1205 II
Methylphenidate........................ 1724 II
Nabilone............................... 7379 II
Cocaine................................ 9041 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Diphenoxylate.......................... 9170 II
Ecgonine............................... 9180 II
Hydrocodone............................ 9193 II
Meperidine............................. 9230 II
Methadone.............................. 9250 II
Methadone intermediate................. 9254 II
Morphine............................... 9300 II
Thebaine............................... 9333 II
Oxymorphone............................ 9652 II
Noroxymorphone......................... 9668 II
Alfentanil............................. 9737 II
Remifentanil........................... 9739 II
Sufentanil............................. 9740 II
Tapentadol............................. 9780 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for sale to its customers.
In reference to drug codes 7360 (marihuana) and 7370 (THC), the
company plans to bulk manufacture these drugs as synthetics. No other
activities for these drug codes are authorized for this registration.
Dated: October 11, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-25133 Filed 10-17-16; 8:45 am]
BILLING CODE 4410-09-P
